|
Camelo-Castillo A, Rivera-Caravaca JM, Orenes-Pinero E, Ramirez-Macias I, Roldan V, Lip GYH, Marin F. Gut Microbiota and the Quality of Oral Anticoagulation in Vitamin K Antagonists Users: A Review of Potential Implications. J Clin Med. 2021 Feb 11;10(4):715. doi: 10.3390/jcm10040715. PubMed PMID: 33670220; PubMed Central PMCID: PMC7916955.
AÑO: 2021; IF: 4.964
|
33670220
|
Bravo-Perez C, Fernandez-Caballero M, Soler-Espejo E, Garcia-Torralba E, Sorigue M, Garcia-Malo MD, Jerez A, Vicente V, Roldan V, de Arriba F. Heparin versus aspirin thromboprophylaxis adds independent value to IMPEDE-VTE score for venous thrombosis prediction in multiple myeloma. J Thromb Thrombolysis. 2021 Oct;52(3):848-853. doi: 10.1007/s11239-021-02407-5. Epub 2021 Mar 1. PubMed PMID: 33649980.
AÑO: 2021; IF: 5.221
|
|
Bravo-Perez C, Serna MJ, Esteban J, Fernandez-Mellid E, Fontanes-Trabazo E, Lorenzo A, Calvino-Suarez M, Minano A, Padilla J, Roldan V, Vicente V, Corral J, de la Morena-Barrio ME. Anticoagulant therapy in patients with congenital FXI deficiency. Blood Adv. 2021 Oct 26;5(20):4083-4086. doi: 10.1182/bloodadvances.2021005695. PubMed PMID: 34597376; PubMed Central PMCID: PMC8945614.
AÑO: 2021; IF: 7.637
|
|
Ding WY, Rivera-Caravaca JM, Marin F, Torp-Pedersen C, Roldan V, Lip GYH. Prediction of Residual Stroke Risk in Anticoagulated Patients with Atrial Fibrillation: mCARS. J Clin Med. 2021 Jul 29;10(15):3357. doi: 10.3390/jcm10153357. PubMed PMID: 34362143; PubMed Central PMCID: PMC8348193.
AÑO: 2021; IF: 4.964
|
|
Proietti M, Esteve-Pastor MA, Rivera-Caravaca JM, Roldan V, Roldan Rabadan I, Muniz J, Cequier A, Bertomeu-Martinez V, Badimon L, Anguita M, Lip GYH, Marin F; FANTASIIA Study Investigators. Relationship between multimorbidity and outcomes in atrial fibrillation. Exp Gerontol. 2021 Oct 1;153:111482. doi: 10.1016/j.exger.2021.111482. Epub 2021 Jul 23. PubMed PMID: 34303775.
AÑO: 2021; IF: 4.253
|